References
- Eloe-Fadrosh EA, Rasko DA. The human microbiome: from symbiosis to pathogenesis. Annu Rev Med. 2013;64:145–163.
- Cho I, Blaser MJ. The human microbiome: at the interface of health and disease. Nat Rev Genet. 2012;13:260–270.
- Lawley TD, Walker AW. Intestinal colonization resistance. Immunology. 2013;138:1–11.
- Britton RA, Young VB. Role of the intestinal microbiota in resistance to colonization by Clostridium difficile. Gastroenterology. 2014;146:1547–1553.
- Rao K, Young VB. Fecal microbiota transplantation for the management of clostridium difficile infection. Infect Dis Clin North Am. 2015;29:109–122.
- Eiseman B, Silen W, Bascom GS, et al. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery. 1958;44:854–859.
- Manges AR, Steiner TS, Wright AJ. Fecal microbiota transplantation for the intestinal decolonization of extensively antimicrobial resistant opportunistic pathogens: a review. Infect Dis (London). 2016;48.
- van Nood E, Vrieze A, Nieuwdorp M, et al. Duodenal infusion of donor feces for recurrent clostridium difficile. N Engl J Med. 2013;368:407–415.
- Halpin AL, de Man TJ, Kraft CS, et al. Intestinal microbiome disruption in patients in a long-term acute care hospital: a case for development of microbiome disruption indices to improve infection prevention. Am J Infect Control. 2016. [Epub ahead of print]. DOI: 10.1016/j.ajic.2016.01.003.
- Lawley TD, Young VB. Murine models to study Clostridium difficile infection and transmission. Anaerobe. 2013;24:94–97.
- Buffie CG, Bucci V, Stein RR, et al. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature. 2015;517:205–208.
- Abt MC, Lewis BB, Caballero S, et al. Innate immune defenses mediated by two ilc subsets are critical for protection against acute clostridium difficile infection. Cell Host Microbe. 2015;18:27–37.
- Lewis BB, Buffie CG, Carter RA, et al. Loss of microbiota-mediated colonization resistance to clostridium difficile infection with oral vancomycin compared with metronidazole. J Infect Dis. 2015;212:1656–1665.
- Vyas D, Aekka A, Vyas A. Fecal transplant policy and legislation. World J Gastroenterol. 2015;21:6–11.
- Thom KA, Johnson JA, Strauss SM, et al. Increasing prevalence of gastrointestinal colonization with ceftazidime-resistant gram-negative bacteria among intensive care unit patients. Infect Control Hosp Epidemiol. 2007;28:1240–1246.
- Safdar N, Bradley EA. The risk of infection after nasal colonization with Staphylococcus aureus. Am J Med. 2008;121:310–315.
- Manning S, Lautenbach E, Tolomeo P, et al. Risk factors for infection with Escherichia coli in nursing home residents colonized with fluoroquinolone-resistant E. coli. Infect Control Hosp Epidemiol. 2015;36:575–577.
- Elizaga ML, Weinstein RA, Hayden MK. Patients in long-term care facilities: a reservoir for vancomycin-resistant enterococci. Clin Infect Dis. 2002;34:441–446.
- Kahvecioglu D, Ramiah K, McMaughan D, et al. Multidrug-resistant organism infections in US nursing homes: a national study of prevalence, onset, and transmission across care settings, October 1, 2010-December 31, 2011. Infect Control Hosp Epidemiol. 2014;35:S48–S55.